Cargando…
Diverse dynamics features of novel protein kinase C (PKC) isozymes determine the selectivity of a fluorinated balanol analogue for PKCε
BACKGROUND: (−)-Balanol is an ATP-mimicking inhibitor that non-selectively targets protein kinase C (PKC) isozymes and cAMP-dependent protein kinase (PKA). While PKA constantly shows tumor promoting activities, PKC isozymes can ambiguously be tumor promoters or suppressors. In particular, PKCε is fr...
Autores principales: | Hardianto, Ari, Khanna, Varun, Liu, Fei, Ranganathan, Shoba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394325/ https://www.ncbi.nlm.nih.gov/pubmed/30717648 http://dx.doi.org/10.1186/s12859-018-2373-1 |
Ejemplares similares
-
Exploration of charge states of balanol analogues acting as ATP-competitive inhibitors in kinases
por: Hardianto, Ari, et al.
Publicado: (2017) -
Opposed Actions of PKA Isozymes (RI and RII) and PKC Isoforms (cPKCβI and nPKCε) in Neuromuscular Developmental Synapse Elimination
por: Garcia, Neus, et al.
Publicado: (2019) -
Differential Roles of the PKC Novel Isoforms, PKCδ and PKCε, in Mouse and Human Platelets
por: Pears, Catherine J., et al.
Publicado: (2008) -
Protein Kinase C (PKC) Isozymes as Diagnostic and Prognostic Biomarkers and Therapeutic Targets for Cancer
por: Kawano, Takahito, et al.
Publicado: (2022) -
A unified approach to the important protein kinase inhibitor balanol and a proposed analogue
por: Saha, Tapan, et al.
Publicado: (2013)